BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1093 related articles for article (PubMed ID: 19412954)

  • 1. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease.
    Volkmann J; Albanese A; Kulisevsky J; Tornqvist AL; Houeto JL; Pidoux B; Bonnet AM; Mendes A; Benabid AL; Fraix V; Van Blercom N; Xie J; Obeso J; Rodriguez-Oroz MC; Guridi J; Schnitzler A; Timmermann L; Gironell AA; Molet J; Pascual-Sedano B; Rehncrona S; Moro E; Lang AC; Lozano AM; Bentivoglio AR; Scerrati M; Contarino MF; Romito L; Janssens M; Agid Y
    Mov Disord; 2009 Jun; 24(8):1154-61. PubMed ID: 19412954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease.
    Moro E; Lozano AM; Pollak P; Agid Y; Rehncrona S; Volkmann J; Kulisevsky J; Obeso JA; Albanese A; Hariz MI; Quinn NP; Speelman JD; Benabid AL; Fraix V; Mendes A; Welter ML; Houeto JL; Cornu P; Dormont D; Tornqvist AL; Ekberg R; Schnitzler A; Timmermann L; Wojtecki L; Gironell A; Rodriguez-Oroz MC; Guridi J; Bentivoglio AR; Contarino MF; Romito L; Scerrati M; Janssens M; Lang AE
    Mov Disord; 2010 Apr; 25(5):578-86. PubMed ID: 20213817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease.
    Sauleau P; Leray E; Rouaud T; Drapier S; Drapier D; Blanchard S; Drillet G; Péron J; Vérin M
    Mov Disord; 2009 Oct; 24(14):2149-55. PubMed ID: 19735089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Temel Y; Wilbrink P; Duits A; Boon P; Tromp S; Ackermans L; van Kranen-Mastenbroek V; Weber W; Visser-Vandewalle V
    Neurosurgery; 2007 Nov; 61(5 Suppl 2):346-55; discussion 355-7. PubMed ID: 18091250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Rothlind JC; Cockshott RW; Starr PA; Marks WJ
    J Int Neuropsychol Soc; 2007 Jan; 13(1):68-79. PubMed ID: 17166305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease.
    Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
    Mov Disord; 2007 Oct; 22(13):1866-70. PubMed ID: 17659634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease.
    Kumar R; Lozano AM; Montgomery E; Lang AE
    Mov Disord; 1998; 13 Suppl 1():73-82. PubMed ID: 9613722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nuclei.
    Just H; Ostergaard K
    Mov Disord; 2002 May; 17(3):539-45. PubMed ID: 12112204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pallidal stimulation in advanced Parkinson's patients with contraindications for subthalamic stimulation.
    Rouaud T; Dondaine T; Drapier S; Haegelen C; Lallement F; Péron J; Raoul S; Sauleau P; Vérin M
    Mov Disord; 2010 Sep; 25(12):1839-46. PubMed ID: 20568094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.